Target intelligence / Profile preview

Fc fragment of IgG, low affinity IIa, receptor pseudogene

Molecular classification
Pseudogene
01

Overview

ENSG00000278215 encodes a pseudogene corresponding to the Fc fragment of IgG, low affinity IIa, receptor, also known as FCGR2A (CD32) pseudogene[3]. As a pseudogene, it does not encode a functional protein product. It is not known to play a direct biological role or serve as a therapeutic target[3]. FCGR2C and other closely related genes in the Fc gamma receptor family can show polymorphisms and gene duplications, contributing to immune diversity[2]; however, ENSG00000278215 specifically refers to an inactivated gene sequence, not an active receptor. ENSG00000278215 is classified as a pseudogene and not a true receptor or active molecule[3]. It does not serve as a receptor, enzyme, or any functional therapeutic target. No biological functions, disease roles, interacting drugs, or clinical biomarker associations are attributed specifically to this pseudogene. Any information related to immune functions, therapeutic antibody responses, or disease mechanisms concerns functional FCGR2A, FCGR2C, or related genes—not the ENSG00000278215 pseudogene itself[2][3]. There is no known clinical or research use of this pseudogene as a biomarker or safety concern. ENSG00000278215 is a non-functional pseudogene and does not correspond to a therapeutic or functional biological target[3]. Any functional or disease-relevant information pertains to closely related true genes (such as FCGR2A or FCGR2C), not this pseudogene[1][2][3][5].

Other names
Fc fragment of IgG, low affinity IIa, receptor pseudogeneFc fragment of IgG receptor IIa (pseudogene)CD32 pseudogeneFCGR2A pseudogene

Beyond the preview

Go deeper on Fc fragment of IgG, low affinity IIa, receptor pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fc fragment of IgG, low affinity IIa, receptor pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call